甲氨蝶呤治疗类风湿关节炎：一项针对以色列患者的免疫遗传学相关性前瞻性研究。
Methotrexate in rheumatoid arthritis: a prospective study in Israeli patients with immunogenetic correlations.
作者信息
Tishler M, Caspi D, Rosenbach T O, Fishel B, Wigler I, Segal R, Gazit E, Yaron M
机构信息
Department of Rheumatology, Ichilov Hospital, Tel Aviv, Israel.
出版信息
Ann Rheum Dis. 1988 Aug;47(8):654-9. doi: 10.1136/ard.47.8.654.
Abstract
In a prospective open study 44 Israeli patients with rheumatoid arthritis were treated with weekly low dose methotrexate (MTX) for up to 36 months. Nine patients withdrew from the study: six because of side effects and three due to inefficacy. One patient died of septicaemia following septic arthritis. Significant improvement, graded by Ritchie articular index, grip strength, physician's global assessment, erythrocyte sedimentation rate (ESR), and platelet counts, was noticed in response to treatment. Seronegative patients had a better clinical response. Transient gastrointestinal symptoms were common and correlated with increases of serum aspartate transaminase (AST). HLA-DR1 and DR7 were significantly associated with increased serum AST concentrations.
摘要
在一项前瞻性开放性研究中，44名以色列类风湿性关节炎患者接受了每周低剂量甲氨蝶呤（MTX）治疗，为期36个月。9名患者退出研究：6名因副作用，3名因无效。1名患者在感染性关节炎后死于败血症。根据里奇关节指数、握力、医生整体评估、红细胞沉降率（ESR）和血小板计数分级，治疗后有显著改善。血清阴性患者有更好的临床反应。短暂的胃肠道症状很常见，且与血清天冬氨酸转氨酶（AST）升高相关。HLA - DR1和DR7与血清AST浓度升高显著相关。
相似文献
1
Methotrexate in rheumatoid arthritis: a prospective study in Israeli patients with immunogenetic correlations.甲氨蝶呤治疗类风湿关节炎：一项针对以色列患者的免疫遗传学相关性前瞻性研究。
Ann Rheum Dis. 1988 Aug;47(8):654-9. doi: 10.1136/ard.47.8.654.
2
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.叶酸和亚叶酸用于减轻类风湿关节炎患者接受甲氨蝶呤治疗时的副作用。
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD000951. doi: 10.1002/14651858.CD000951.pub2.
3
Long-term treatment of destructive rheumatoid arthritis with methotrexate.甲氨蝶呤对破坏性类风湿关节炎的长期治疗
J Rheumatol. 1997 Oct;24(10):1881-9.
4
The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients.亚叶酸（甲酰四氢叶酸）对类风湿关节炎患者甲氨蝶呤治疗效果的影响。
Arthritis Rheum. 1988 Jul;31(7):906-8. doi: 10.1002/art.1780310712.
5
Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases.甲氨蝶呤治疗类风湿关节炎：191例前瞻性开放性长期研究
J Rheumatol. 1991 Sep;18(9):1323-7.
6
Every-other-week methotrexate in patients with rheumatoid arthritis. A double-blind, placebo-controlled prospective study.类风湿关节炎患者每两周一次甲氨蝶呤治疗。一项双盲、安慰剂对照的前瞻性研究。
Arthritis Rheum. 1995 May;38(5):601-7. doi: 10.1002/art.1780380504.
7
Toxicity of methotrexate in rheumatoid arthritis.甲氨蝶呤在类风湿关节炎中的毒性
J Rheumatol. 1987 Feb;14(1):74-9.
8
Methotrexate for treating rheumatoid arthritis.甲氨蝶呤用于治疗类风湿关节炎。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD000957. doi: 10.1002/14651858.CD000957.pub2.
9
Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial.柳氮磺胺吡啶与甲氨蝶呤联合用药对比单一成分用于早期类风湿性关节炎的疗效：一项随机、对照、双盲、为期52周的临床试验
Br J Rheumatol. 1997 Oct;36(10):1082-8. doi: 10.1093/rheumatology/36.10.1082.
10
Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study.甲氨蝶呤治疗类风湿关节炎。一项为期五年的前瞻性多中心研究。
Arthritis Rheum. 1994 Oct;37(10):1492-8. doi: 10.1002/art.1780371013.
引用本文的文献
1
A risk-benefit assessment of methotrexate in corticosteroid-dependent asthma.甲氨蝶呤用于皮质类固醇依赖型哮喘的风险效益评估。
Drug Saf. 1996 Oct;15(4):283-90. doi: 10.2165/00002018-199615040-00006.
2
Disease-modifying antirheumatic drugs. Potential effects in older patients.改善病情抗风湿药。对老年患者的潜在影响。
Drugs Aging. 1995 Dec;7(6):420-37. doi: 10.2165/00002512-199507060-00003.
3
Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent?甲氨蝶呤用于类风湿关节炎：当前的知识和经验能否证明其作为一线病情改善药物使用的合理性？
Postgrad Med J. 1993 Oct;69(816):775-80. doi: 10.1136/pgmj.69.816.775.
4
Long-term experience with low dose methotrexate in rheumatoid arthritis.小剂量甲氨蝶呤治疗类风湿关节炎的长期经验
Rheumatol Int. 1993;13(3):103-6. doi: 10.1007/BF00290296.
5
Methotrexate therapy in rheumatoid arthritis. A two year prospective follow-up.类风湿关节炎的甲氨蝶呤治疗。一项为期两年的前瞻性随访。
Clin Rheumatol. 1990 Sep;9(3):333-41. doi: 10.1007/BF02114393.
6
Drug toxicity.药物毒性。
Ann Rheum Dis. 1990 May;49(5):331-6. doi: 10.1136/ard.49.5.331.
7
Intra-articular steroids: confounder of clinical trials.关节内注射类固醇：临床试验的混杂因素。
Clin Rheumatol. 1991 Mar;10(1):38-42. doi: 10.1007/BF02208031.
8
Controlled trial of methotrexate versus 10-deazaaminopterin in the treatment of rheumatoid arthritis.甲氨蝶呤与10-脱氮氨基蝶呤治疗类风湿关节炎的对照试验。
Ann Rheum Dis. 1992 May;51(5):600-3. doi: 10.1136/ard.51.5.600.
9
A prospective analysis of liver biopsies in rheumatoid arthritis patients receiving long term methotrexate therapy.对接受长期甲氨蝶呤治疗的类风湿关节炎患者肝脏活检的前瞻性分析。
Rheumatol Int. 1992;12(1):39-41. doi: 10.1007/BF00246875.
10
Methotrexate treatment of rheumatoid arthritis: is a fortnightly maintenance schedule enough?甲氨蝶呤治疗类风湿关节炎：每两周一次的维持治疗方案足够吗？
Ann Rheum Dis. 1992 Dec;51(12):1330-1. doi: 10.1136/ard.51.12.1330.
本文引用的文献
1
Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis.组织反应性的治疗性抑制。II. 氨甲蝶呤对类风湿性关节炎和银屑病的作用。
Am J Med Sci. 1951 Feb;221(2):176-82.
2
Preliminary criteria for clinical remission in rheumatoid arthritis.类风湿关节炎临床缓解的初步标准。
Arthritis Rheum. 1981 Oct;24(10):1308-15. doi: 10.1002/art.1780241012.
3
4
Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis.HLA-Aw31和HLA-DR1与成人类风湿性关节炎的关联。
Ann Rheum Dis. 1982 Aug;41(4):403-4. doi: 10.1136/ard.41.4.403.
5
Amethopterin (methotrexate) in connective tissue disease-psoriasis and polyarthritis.氨甲蝶呤（甲氨蝶呤）在结缔组织病——银屑病和多关节炎中的应用
Ann Rheum Dis. 1968 Jan;27(1):64-6. doi: 10.1136/ard.27.1.64.
6
Low-dose methotrexate treatment of rheumatoid arthritis. Long-term observations.低剂量甲氨蝶呤治疗类风湿关节炎。长期观察。
Am J Med. 1985 Sep;79(3):331-7. doi: 10.1016/0002-9343(85)90312-2.
7
Efficacy of low-dose methotrexate in rheumatoid arthritis.低剂量甲氨蝶呤治疗类风湿关节炎的疗效
N Engl J Med. 1985 Mar 28;312(13):818-22. doi: 10.1056/NEJM198503283121303.
8
The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis.甲氨蝶呤用于类风湿关节炎长期治疗的安全性和有效性。
Arthritis Rheum. 1986 Jul;29(7):822-31. doi: 10.1002/art.1780290702.
Zotero 插件